Naropin (ropivacaine): Reviews and patient testimonials
Medication indications
Naropin 10 mg/ml solution for injection
Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery, including Caesarean section.
- Major nerve blocks.
- Field blocks.
Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery.
Naropin 2 mg/ml is indicated for acute pain management
In adults and adolescents above 12 years of age for:
- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.
- Field blocks.
- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.
In infants from 1 year and children up to and including 12 years of age (per- and postoperative):
- Single and continuous peripheral nerve block.
In neonates, infants and children up to and including 12 years of age for (per- and postoperative):
- Caudal epidural block.
- Continuous epidural infusion.
Naropin 2 mg/ml solution for infusion
Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery, including Caesarean section.
- Major nerve blocks.
- Field blocks.
Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery.
Naropin 2 mg/ml is indicated for acute pain management
In adults and adolescents above 12 years of age for:
- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.
- Field blocks.
- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.
In infants from 1 year and children up to and including 12 years of age (per- and postoperative):
- Single and continuous peripheral nerve block.
In neonates, infants and children up to and including 12 years of age for (per- and postoperative):
- Caudal epidural block.
- Continuous epidural infusion.
Naropin 2 mg/ml solution for injection
Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery, including Caesarean section.
- Major nerve blocks.
- Field blocks.
Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery.
Naropin 2 mg/ml is indicated for acute pain management
In adults and adolescents above 12 years of age for:
- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.
- Field blocks.
- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.
In infants from 1 year and children up to and including 12 years of age (per- and postoperative):
- Single and continuous peripheral nerve block.
In neonates, infants and children up to and including 12 years of age for (per- and postoperative):
- Caudal epidural block.
- Continuous epidural infusion.
Naropin 7.5 mg/ml solution for injection
Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery, including Caesarean section.
- Major nerve blocks.
- Field blocks.
Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:
Surgical anaesthesia:
- Epidural blocks for surgery.
Naropin 2 mg/ml is indicated for acute pain management
In adults and adolescents above 12 years of age for:
- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.
- Field blocks.
- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.
In infants from 1 year and children up to and including 12 years of age (per- and postoperative):
- Single and continuous peripheral nerve block.
In neonates, infants and children up to and including 12 years of age for (per- and postoperative):
- Caudal epidural block.
- Continuous epidural infusion.
Route of administration: Injectable
Molecule: ropivacaine
Patients' opinions on Naropin
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
                                
                                10 = Extremely satisfied
                                    1 = Not at all satisfied
                                    
                                    10 = Extremely satisfied
                                
                                    1 = Not at all satisfied
                                    
                                    10 = Extremely satisfied
                                
                                    1 = Never
                                    
                                    10 = Always
                                
                                    1 = Not at all important
                                    
                                    10 = Extremely important
                                
                                    1 = Not at all satisfied
                                    
                                    10 = Extremely satisfied
                                
 Back to the list of medications
                    Back to the list of medications
                
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.